Acute Anterior Cruciate Ligament Rupture; RecOnsTruction Or Repair?

December 1, 2014, 9:00 am

≫ Next: Additional Lidocaine Spray on the Tip of Endoscope Can Improve Tolerance of Endoscopy

$

0

0

Condition:   Anterior Cruciate Ligament Injury
Interventions:   Procedure: ACL Repair;   Procedure: ACL reconstruction
Sponsor:   Orthopedisch Centrum Oost Nederland
Not yet recruiting - verified December 2014

---

Additional Lidocaine Spray on the Tip of Endoscope Can Improve Tolerance of Endoscopy

December 1, 2014, 9:00 am

≫ Next: The Leaky Lung Test

≪ Previous: Acute Anterior Cruciate Ligament Rupture; RecOnsTruction Or Repair?

$

0

0

Conditions:   C.Medical Procedure; Digestive System;   Disorder of Upper Gastrointestinal Tract;   Tolerance
Intervention:   Drug: Case Group
Sponsor:   Cheju Halla General Hospital
Completed - verified December 2014

The Leaky Lung Test

December 1, 2014, 9:00 am

≫ Next: Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Non-Healing Wounds

≪ Previous: Additional Lidocaine Spray on the Tip of Endoscope Can Improve Tolerance of Endoscopy

$

0

0

Conditions:   Asthma;   Allergy;   Reactive Airway Disease;   Lung Diseases, Obstructive
Intervention:   Drug: Mannitol
Sponsors:   University of Rochester;   National Institutes of Health (NIH);   Pharmaxis;   National Heart, Lung, and Blood Institute (NHLBI)
Not yet recruiting - verified December 2014

Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Non-Healing Wounds

December 2, 2014, 9:00 am

≫ Next: Evaluation of Myocardial Perfusion Heterogeneity Imaging in Diabetes Patients (EVADIAB)

≪ Previous: The Leaky Lung Test

$

0

0

Conditions:   Foot Ulcer Chronic;   Skin Ulcer Venous Stasis Chronic;   Pressure Ulcer
Interventions:   Procedure: Platelet Rich Plasma;   Procedure: Standard of Care
Sponsor:   ACR Biologics, LLC
Not yet recruiting - verified December 2014

Evaluation of Myocardial Perfusion Heterogeneity Imaging in Diabetes Patients (EVADIAB)

December 2, 2014, 9:00 am

≫ Next: Lidocaine With Epinephrine vs. Bupivacaine With Epinephrine as Local Anesthetic Agents in Wide-awake Hand Surgery

≪ Previous: Effectiveness of Autologous Platelet Rich Plasma in the Treatment of Chronic Non-Healing Wounds

$

0

0

Condition:   Type 2 Diabetes
Intervention:   Device: MPHI
Sponsor:   University Hospital, Grenoble
Recruiting - verified December 2014

Lidocaine With Epinephrine vs. Bupivacaine With Epinephrine as Local Anesthetic Agents in Wide-awake Hand Surgery

December 3, 2014, 9:00 am

≫ Next: Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

≪ Previous: Evaluation of Myocardial Perfusion Heterogeneity Imaging in Diabetes Patients (EVADIAB)

$

0

0

Condition:   Carpal Tunnel Syndrome
Intervention:   Procedure: Wrist block anesthesia
Sponsor:   Dr Mario Luc
Recruiting - verified December 2014

Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

December 4, 2014, 9:00 am

≫ Next: Local Assessment of Management of Burn Patients

≪ Previous: Lidocaine With Epinephrine vs. Bupivacaine With Epinephrine as Local Anesthetic Agents in Wide-awake Hand Surgery

$

0

0

Conditions:   Myeloproliferative Neoplasm;   Primary Myelofibrosis;   Essential Thrombocythemia;   Polycythemia Vera
Intervention:   Drug: Mirabegron
Sponsor:   Swiss Group for Clinical Cancer Research
Not yet recruiting - verified December 2014

Local Assessment of Management of Burn Patients

December 4, 2014, 9:00 am

≫ Next: Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation

≪ Previous: Sympathicomimetic Agonist in Patients With Myeloproliferative Neoplasms With JAK2-mutation

$

0

0

Conditions:   Burns - Multiple;   Mechanical Ventilation
Intervention:   Other: No intervention
Sponsor:   Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Not yet recruiting - verified December 2014

---

Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation

December 4, 2014, 9:00 am

≫ Next: Split-face Study of Changing in Skin Physiology and Clinical Appearance After Microdroplet Placement of Stabilized Hyaluronic Acid in Aging Faces

≪ Previous: Local Assessment of Management of Burn Patients

$

0

0

Condition:   Medical Abortion
Intervention:   Drug: Mifepristone followed by misoprostol 24-48 hours later
Sponsor:   Gynuity Health Projects
Not yet recruiting - verified December 2014

Split-face Study of Changing in Skin Physiology and Clinical Appearance After Microdroplet Placement of Stabilized Hyaluronic Acid in Aging Faces

December 5, 2014, 9:00 am

≫ Next: To Investigate Pharmacokinetics (Absorption, Distribution, Elimination), Safety and Tolerability of a Single Oral Dose of 75 mg Molidustat Tablet in Male and Female Subjects Requiring Hemo- or Peritoneal Dialysis Compared to Healthy Subjects

≪ Previous: Outpatient Medical Abortion With Mifepristone and Misoprostol Through 77 Days of Gestation

$

0

0

Condition:   Efficacy and Safety of NASHA Using a Stamp-type Electronic Multineedle Injector
Intervention:   Device: Restylane Vital
Sponsor:   Konkuk University Hospital
Completed - verified December 2014

To Investigate Pharmacokinetics (Absorption, Distribution, Elimination), Safety and Tolerability of a Single Oral Dose of 75 mg Molidustat Tablet in Male and Female Subjects Requiring Hemo- or Peritoneal Dialysis Compared to Healthy Subjects

December 5, 2014, 9:00 am

≫ Next: Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial

≪ Previous: Split-face Study of Changing in Skin Physiology and Clinical Appearance After Microdroplet Placement of Stabilized Hyaluronic Acid in Aging Faces

$

0

0

Condition:   Renal Insufficiency, Chronic
Interventions:   Drug: Molidustat(BAY85-3934);   Drug: Molidustat(BAY85-3934)
Sponsor:   Bayer
Not yet recruiting - verified December 2014

Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial

December 5, 2014, 9:00 am

≫ Next: Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy

≪ Previous: To Investigate Pharmacokinetics (Absorption, Distribution, Elimination), Safety and Tolerability of a Single Oral Dose of 75 mg Molidustat Tablet in Male and Female Subjects Requiring Hemo- or Peritoneal Dialysis Compared to Healthy Subjects

$

0

0

Condition:   Migraine Disorders
Interventions:   Drug: Metoclopramide 10 mg;   Drug: Placebo;   Drug: Fentanyl
Sponsor:   Kocaeli University
Recruiting - verified December 2014

Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy

December 5, 2014, 9:00 am

≫ Next: Evaluation of the Safety and Effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator in Patients With Dry Eye

≪ Previous: Intravenous Metoclopramide in the Acute Treatment of Migraine: A Double-blind, Randomized, Placebo-controlled Trial

$

0

0

Condition:   Liver Disease
Intervention:  
Sponsor:   National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Enrolling by invitation - verified October 2014

Evaluation of the Safety and Effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator in Patients With Dry Eye

December 8, 2014, 9:00 am

≫ Next: Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery

≪ Previous: Comparing Pain in Patients Undergoing Percutaneous Versus Transjugular Techniques of Liver Biopsy

$

0

0

Condition:   Dry Eye Syndromes
Intervention:   Device: Oculeve Intranasal Lacrimal Neurostimulator
Sponsors:   Oculeve, Inc.;   ORA, Inc.
Recruiting - verified December 2014

Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery

December 9, 2014, 9:00 am

≫ Next: Rhythm and Music to Rehabilitate Reading Disorders

≪ Previous: Evaluation of the Safety and Effectiveness of the Oculeve Intranasal Lacrimal Neurostimulator in Patients With Dry Eye

$

0

0

Conditions:   Fallopian Tube Carcinoma;   Ovarian Carcinoma;   Primary Peritoneal Carcinoma;   Stage IIIA Uterine Corpus Cancer;   Stage IIIB Uterine Corpus Cancer;   Stage IIIC Uterine Corpus Cancer;   Stage IVA Uterine Corpus Cancer;   Stage IVB Uterine Corpus Cancer
Interventions:   Other: Comprehensive Geriatric Assessment;   Other: Questionnaire Administration
Sponsors:   NRG Oncology;   National Cancer Institute (NCI)
Not yet recruiting - verified December 2014

---

Rhythm and Music to Rehabilitate Reading Disorders

December 9, 2014, 9:00 am

≫ Next: Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study

≪ Previous: Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery

$

0

0

Condition:   Reading Disability
Interventions:   Behavioral: Music training;   Behavioral: Visual arts
Sponsors:   Aix Marseille Université;   WHO Collaborating Centre for Maternal and Child Health, Trieste;   University of Roma La Sapienza
Completed - verified December 2014

Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study

December 9, 2014, 9:00 am

≫ Next: Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer

≪ Previous: Rhythm and Music to Rehabilitate Reading Disorders

$

0

0

Condition:   Osteoporosis
Intervention:   Radiation: Quantitative computed tomography scan for bone density analysis
Sponsors:   University of Mississippi Medical Center;   National Institute of Dental and Craniofacial Research (NIDCR)
Not yet recruiting - verified December 2014

Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer

December 10, 2014, 9:00 am

≫ Next: KINECTing Postoperative Pain and Recovery Following Orthopedic Surgery

≪ Previous: Salivary-based Bone Loss Marker Detection Platform for Point-of-care Screening - Phase II Study

$

0

0

Conditions:   Stage III Bladder Cancer;   Stage IV Bladder Cancer
Interventions:   Procedure: therapeutic conventional surgery;   Radiation: intensity-modulated radiation therapy
Sponsors:   NRG Oncology;   National Cancer Institute (NCI)
Not yet recruiting - verified December 2014

KINECTing Postoperative Pain and Recovery Following Orthopedic Surgery

December 10, 2014, 9:00 am

≫ Next: Nivolumab in Treating Patients With Refractory Metastatic Squamous Cell Carcinoma of the Anal Canal

≪ Previous: Surgery With or Without Postoperative Intensity Modulated Radiation Therapy in Treating Patients With Urothelial Bladder Cancer

$

0

0

Condition:   Pain, Postoperative
Intervention:   Device: single-arm study group (motion detection wrist band and a KINECT-based video)
Sponsor:   University of Florida
Not yet recruiting - verified December 2014

Nivolumab in Treating Patients With Refractory Metastatic Squamous Cell Carcinoma of the Anal Canal

December 10, 2014, 9:00 am

≫ Next: A Study to Evaluate Safety and Efficacy of ASP015K in Patients With Rheumatoid Arthritis (RA) Who Had an Inadequate Response to DMARDs

≪ Previous: KINECTing Postoperative Pain and Recovery Following Orthopedic Surgery

$

0

0

Conditions:   Anal Canal Squamous Cell Carcinoma;   Metastatic Anal Canal Carcinoma;   Recurrent Anal Canal Carcinoma
Interventions:   Biological: Nivolumab;   Other: Laboratory Biomarker Analysis
Sponsor:   National Cancer Institute (NCI)
Not yet recruiting - verified December 2014